Skeletal Dysplasia Account Manager - Boston, MA

Role: Skeletal Dysplasia Account Manager responsible for launching Infigratinib for achondroplasia, focusing on community engagement, provider partnerships, and market development in Northeast US territories. Responsibilities include developing and executing territory business plans targeting specialists such as geneticists, pediatric endocrinologists, and orthopedic surgeons; demonstrating deep clinical expertise; leveraging data to identify growth opportunities; collaborating with internal teams and KOLs; and ensuring compliance with regulations. Requirements: 8–10 years in pharma/biotech, 4+ years in rare or genetic diseases, with experience in product launches, account management, and stakeholder engagement; BS/BA degree required, MBA preferred. Skills in clinical knowledge, strategic planning, influence, resilience, and AI fluency are essential. Experience in pediatric rare diseases, especially achondroplasia or skeletal dysplasia, is highly preferred. The role entails extensive travel within the region and necessitates strong communication and leadership skills, with a focus on building trust and advocacy among healthcare providers and families. The position offers a competitive salary range of $155,000 - $210,000, along with comprehensive benefits, including health coverage, stock options, and professional development opportunities.